The Beauty Health Company
NASDAQ:SKINHousehold & Personal Products
+$0.04 today
- Market cap
- $81.18M
- Beta
- 1.07
- P/E (TTM)
- -14.6
- EPS (TTM)
- -$0.05
Volume 0.05M
Average 0.95M
SKIN Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
The Beauty Health CompanyNASDAQ: SKIN
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities rises 1191.2% from a year ago
Other current liabilities stood at $31.75M at the end of Q1 FY2026, up 1191.2% from a year earlier and down 21.3% from the prior quarter. Over 3 fiscal years it compounded at +92.7% a year.
Context
- Other current liabilities amounted to 6.7% of total assets at the end of Q1 FY2026, up 6.3 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +1191.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 40.36M USD
- Year-over-year change
- +1782.3%
- 4-year CAGR
- +21.9%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 40.36M | +1782.3% |
| FY2024 | 2024-12-31 | 2.14M | -91.4% |
| FY2023 | 2023-12-31 | 25.01M | +343.3% |
| FY2022 | 2022-12-31 | 5.64M | -69.1% |
| FY2021 | 2021-12-31 | 18.28M | — |
Other Current Liabilities vs competitors
How SKIN compares with its peers on the latest reported figures
- Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +1191.2% is the highest of 6, against a peer median of +44.6%.
- Other current liabilities amounts to 6.7% of total assets for SKIN, versus a peer median of 3.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | CN¥63.43M CNY | +374.6% | -32.7% | 5.1% | |
| Apr 2026 | $53.82M USD | +84.7% | -16.6% | 6.3% | |
| Mar 2026 | $31.75M USD | +1191.2% | +92.7% | 6.7% | |
| Mar 2026 | $13.62M USD | +22.7% | +3.9% | 7.0% | |
| Mar 2026 | $1.35M USD | -55.3% | +3.3% | 2.3% | |
| Mar 2026 | $830K USD | +44.6% | +20.8% | 0.8% | |
SLSNSolesence, Inc. Common Stock | Mar 2026 | $0 USD | — | — | 0.0% |
| Peer median (excluding SKIN) | — | +44.6% | +3.3% | 3.7% | |
Competitors are the stored peer set for SKIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 901.89M | 568.2M | 523.03M | 370.06M | 232.7M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 51.42M | 77.77M | 55.03M | 28.46M | 23.44M |
| Inventory | 35.26M | 109.66M | 91.32M | 69.11M | 48M |
| Other Current Assets | 12.32M | 27.65M | 28.88M | 9.49M | 5.36M |
| Total Current Assets | 1B | 783.28M | 698.25M | 477.12M | 309.5M |
| Property, Plant & Equipment (Net) | 31.18M | 33.82M | 26.35M | 19.57M | 14.1M |
| Goodwill | 123.69M | 124.59M | 125.82M | 123.5M | 126.6M |
| Intangible Assets | 56.01M | 46.39M | 62.12M | 47.51M | 35.8M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 330K | 815K | 531K | 3.89M | 1.9M |
| Other Non-current Assets | 6.71M | 14.19M | 16.04M | 14.09M | 11.9M |
| Total Non-current Assets | 217.91M | 219.81M | 230.86M | 208.56M | 190.3M |
| Total Assets | 1.22B | 1B | 929.11M | 685.68M | 499.8M |
| Account Payables | 29.05M | 28.47M | 44.77M | 21.94M | 15.6M |
| Short-term Debt | 0 | 0 | 0 | 0 | 129.09M |
| Tax Payables | 7.03M | 11.84M | 18.19M | 19.38M | 1.2M |
| Deferred Revenue | 0 | 0 | 450K | 2.38M | 0 |
| Other Current Liabilities | 18.28M | 5.64M | 25.01M | 2.14M | 40.36M |
| Total Current Liabilities | 76.44M | 71.71M | 115.01M | 68.15M | 186.3M |
| Long-term Debt | 729.91M | 734.14M | 738.37M | 552.2M | 240.43M |
| Deferred Tax Liabilities | 3.56M | 2.01M | 702K | 396K | 393K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 93.82M | 15.47M | 6.32M | 2.32M | 2.41M |
| Total Non-current Liabilities | 840.07M | 764.32M | 754.72M | 565.73M | 252.47M |
| Total Liabilities | 916.51M | 836.03M | 869.72M | 633.88M | 438.7M |
| Common Stock | 16K | 14K | 12K | 12K | 13K |
| Retained Earnings | (418.71M) | (378.75M) | (478.87M) | (507.97M) | (517.5M) |
| Accumulated OCI | (1.26M) | (4.53M) | (3.04M) | (6.95M) | (1.4M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 302.3M | 167.05M | 59.39M | 51.8M | 61.1M |
| Total Debt | 746.41M | 751.79M | 752.29M | 568.16M | 378.7M |
| Net Debt | (155.48M) | 183.59M | 229.26M | 198.1M | 146M |
The Beauty Health Company
NASDAQ:SKIN
Intrinsic Alpha fair value
Locked
Current Price
$12.46
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.